Bank of Montreal’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.5M Sell
31,864
-3,252
-9% -$1.11M ﹤0.01% 1072
2025
Q4
$14M Buy
35,116
+25,183
+254% +$11.1M 0.01% 986
2025
Q3
$4.53M Sell
9,933
-3,178
-24% -$1.29M ﹤0.01% 1331
2025
Q2
$4.28M Buy
13,111
+2,427
+23% +$672K ﹤0.01% 1307
2025
Q1
$2.88M Sell
10,684
-923
-8% -$237K ﹤0.01% 1378
2024
Q4
$2.73M Sell
11,607
-10,184
-47% -$2.68M ﹤0.01% 1436
2024
Q3
$5.99M Sell
21,791
-9,385
-30% -$2.44M ﹤0.01% 1237
2024
Q2
$7.66M Sell
31,176
-71,332
-70% -$11.3M ﹤0.01% 1113
2024
Q1
$15.9M Buy
102,508
+62,543
+156% +$10.4M 0.01% 821
2023
Q4
$7.87M Sell
39,965
-8,238
-17% -$1.4M ﹤0.01% 1113
2023
Q3
$8.96M Sell
48,203
-11,301
-19% -$2.16M ﹤0.01% 1034
2023
Q2
$12.2M Buy
59,504
+1,776
+3% +$352K ﹤0.01% 938
2023
Q1
$11.6M Buy
57,728
+33,660
+140% +$7.08M ﹤0.01% 881
2022
Q4
$5.73M Sell
24,068
-34,081
-59% -$7.27M ﹤0.01% 1224
2022
Q3
$12.3K Sell
58,149
-18,932
-25% -$3.61M 0.01% 891
2022
Q2
$11.2K Buy
77,081
+3,330
+5% +$472K 0.01% 1008
2022
Q1
$12.4M Buy
73,751
+34,267
+87% +$5.22M 0.01% 1048
2021
Q4
$6.85M Sell
39,484
-13,857
-26% -$2.58M ﹤0.01% 1116
2021
Q3
$9.52M Buy
53,341
+10,590
+25% +$1.99M ﹤0.01% 1332
2021
Q2
$7.11M Buy
42,751
+568
+1% +$83.2K ﹤0.01% 1438
2021
Q1
$6.01M Sell
42,183
-2,962
-7% -$446K ﹤0.01% 1257
2020
Q4
$7.07M Sell
45,145
-9,955
-18% -$1.33M 0.01% 1208
2020
Q3
$7.89M Sell
55,100
-9,724
-15% -$1.38M 0.01% 967
2020
Q2
$10.3M Buy
64,824
+1,745
+3% +$235K 0.01% 824
2020
Q1
$6.57M Buy
63,079
+4,622
+8% +$534K 0.01% 867
2019
Q4
$6.73M Sell
58,457
-890
-1% -$88.7K 0.01% 1193
2019
Q3
$4.77M Buy
59,347
+693
+1% +$54.8K ﹤0.01% 1232
2019
Q2
$4.26M Sell
58,654
-15,076
-20% -$1.16M ﹤0.01% 1290
2019
Q1
$6.89M Buy
73,730
+4,482
+6% +$375K 0.01% 995
2018
Q4
$5.05M Buy
69,248
+4,038
+6% +$311K 0.01% 1072
2018
Q3
$5.71M Buy
65,210
+14,364
+28% +$1.44M ﹤0.01% 1127
2018
Q2
$5.01M Buy
50,846
+1,272
+3% +$126K ﹤0.01% 1165
2018
Q1
$5.9M Buy
49,574
+33,712
+213% +$4.35M 0.01% 1081
2017
Q4
$2.02M Buy
15,862
+5,959
+60% +$749K ﹤0.01% 1571
2017
Q3
$1.16M Sell
9,903
-71
-0.7% -$6.06K ﹤0.01% 1907
2017
Q2
$796K Buy
9,974
+446
+5% +$28.5K ﹤0.01% 2085
2017
Q1
$488K Buy
9,528
+7,044
+284% +$326K ﹤0.01% 2113
2016
Q4
$109K Buy
2,484
+1,925
+344% +$80.6K ﹤0.01% 2789
2016
Q3
$38K Sell
559
-2,900
-84% -$205K ﹤0.01% 3131
2016
Q2
$193K Sell
3,459
-49,051
-93% -$3.09M ﹤0.01% 2487
2016
Q1
$3.3M Buy
52,510
+19,210
+58% +$1.28M ﹤0.01% 1196
2015
Q4
$3.13M Sell
33,300
-6,008
-15% -$557K ﹤0.01% 1192
2015
Q3
$3.16M Buy
39,308
+35,936
+1,066% +$3.99M ﹤0.01% 1115
2015
Q2
$405K Buy
3,372
+3,170
+1,569% +$379K ﹤0.01% 2072
2015
Q1
$21K Sell
202
-163
-45% -$16.5K ﹤0.01% 3248
2014
Q4
$35K Buy
365
+176
+93% +$16.3K ﹤0.01% 3161
2014
Q3
$15K Sell
189
-1,460
-89% -$94.2K ﹤0.01% 3547
2014
Q2
$104K Buy
1,649
+1,460
+772% +$86.8K ﹤0.01% 2815
2014
Q1
$13K Hold
189
﹤0.01% 3596
2013
Q4
$12K Hold
189
﹤0.01% 3347
2013
Q3
$12K Hold
189
﹤0.01% 3372
2013
Q2
$6K Buy
+189
New +$5.03K ﹤0.01% 3406

Other funds holding ALNY